AC Immune (ACIU) Non-Current Debt (2017 - 2025)
AC Immune's (ACIU) quarterly Non-Current Debt came in at $1.8 million in Q3 2025, up 62.52% year-on-year from $1.1 million in Q3 2024, and down 19.98% on a QoQ basis from $2.3 million in Q1 2025.
AC Immune (ACIU) Non-Current Debt (2017 - 2025) Analysis & Trends
AC Immune (ACIU) has 9 years of Non-Current Debt data on file, last reported at $1.8 million in Q3 2025.
- On a quarterly basis, Non-Current Debt rose 62.52% year-over-year to $1.8 million in Q3 2025; TTM through Sep 2025 was $1.8 million, a 62.52% increase from a year earlier, with the FY2018 full-year figure at $186899.3, down 62.67% from the prior year.
- Non-Current Debt for Q3 2025 stood at $1.8 million, down from $2.3 million in the prior quarter.
- Over the last five years, Non-Current Debt for ACIU reached as high as $2.3 million in Q1 2025 and fell as low as $836660.7 in Q3 2023.
- Historically, Non-Current Debt has averaged $1.2 million across 5 years, with a median of $1.1 million in 2023.
- Across the five-year window, Non-Current Debt dropped 11.7% in 2022 and surged 62.52% in 2025, its largest moves.
- Year by year, Non-Current Debt stood at $889818.5 in 2021, then advanced by 5.02% to $934463.7 in 2022, then decreased by 10.47% to $836660.7 in 2023, then soared by 34.51% to $1.1 million in 2024, then jumped by 62.52% to $1.8 million in 2025.
- Per Business Quant data, the three most recent Non-Current Debt figures were $1.8 million in Q3 2025, $2.3 million in Q1 2025, and $1.1 million in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 105.94 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 842.92 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.99 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | AC Immune | 225.68 Mn | 225.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1.83 Mn |
| Mar 31, 2025 | 2.29 Mn |
| Sep 30, 2024 | 1.13 Mn |
| Mar 31, 2024 | 1.51 Mn |
| Sep 30, 2023 | 836,660.74 |
| Mar 31, 2023 | 1.12 Mn |
| Jun 30, 2022 | 934,463.71 |
| Mar 31, 2022 | 1.14 Mn |
| Sep 30, 2021 | 889,818.48 |
| Jun 30, 2021 | 1.06 Mn |
| Mar 31, 2021 | 897,013.90 |
| Sep 30, 2020 | 640,955.64 |
| Sep 30, 2019 | 301,440.55 |
| Jun 30, 2019 | 255.31 |
| Mar 31, 2019 | 225,914.07 |
| Dec 31, 2018 | 186,899.27 |
| Dec 31, 2017 | 500,708.16 |
| Sep 30, 2017 | 196.43 Mn |
| Jun 30, 2017 | 191,834.75 |